(2023) Liposomal Doxorubicin Kinetic Study in an In vitro 2D and 3D Tumor Model for Osteosarcoma in a Perfusion Bioreactor. Pharmaceutical nanotechnology. pp. 447-459. ISSN 2211-7393 (Electronic) 2211-7385 (Linking)